hers tirzepatide Hims & Expands Weight Loss Offering, Adds Lilly's Zepbound to Platform Full Range of FDA-Approved GLP-1s

More than half (54%) of those who take GLP-1s for weight loss spend less than a year on the medication, while just 18% stay on them for more than two years, according to a Sermo physician survey

Influences sleep homeostasis and delta (deep) sleep stages

Stronger products may be more likely to cause redness, tingling, itching, dryness, or irritation, especially if your skin barrier is already sensitive

Over the past decades, metyrapone has been extensively used as off-label therapy in the management of CD patients

Med Microecology

A versatile collection of pyrimidine-2,4-diones has been reported as DPP-4 inhibitors, with trelagliptin, linagliptin, and alogliptin being well-established members of this group